FDA peptide compounding signals, tracked in one place.
Take the 90-second pathway quiz for a personalized education-only brief, then use PeptideUnicorn's tracker, peptide profiles, and regulatory coverage to keep researching. Independent. Editorially reviewed. We do not prescribe, dispense, or route care.
Pathway Quiz Preview
A faster first step than browsing cold.
Legal status brief
Included in your personalized research brief
Evidence match
Included in your personalized research brief
Next-step pathway
Included in your personalized research brief
Answer 8 questions to see country-aware legal context, evidence notes, and regulated vs research-path guidance.
Find your peptide pathway in 90 seconds.
Answer 8 questions. Get a personalized brief covering legal status in your country, evidence levels for your goals, and where to go next: regulated compounding vs research vendors.
Legal status brief
Evidence match
Next-step pathway
Choose the path that matches what you need.
Research, regulation, and practical tools stay separated so readers can move without mistaking education for medical advice.
I want to understand a peptide
Start with evidence summaries, common names, and legal context.
I want to check legality and regulation
Track FDA, MHRA, TGA, EU, and WADA coverage from one hub.
I want practical guides and tools
Use calculators, COA guides, storage explainers, and safety-first references.
Follow the FDA compounding watchlist.
Filter peptides by FDA signal, use case, and latest editorial review date.
The tracker brings 20 profile-linked FDA source signals, confidence notes, profile links, and jurisdiction summaries into one practical view.
BPC-157
Updated 28 May 2026
KPV
Updated 28 May 2026
TB-500
Updated 28 May 2026
MOTS-c
Updated 28 May 2026
Start with the biggest current stories.
Report
State of Peptides 2026
A citation-heavy 2026 report on peptide demand, GLP-1 enforcement, FDA compounding policy, Category 2 peptide risk, and next-generation obesity trials.
News
Most Trending Peptides in 2026: What Demand Is Actually Concentrated Around
A practical, source-backed breakdown of the peptide categories attracting the most demand in 2026, from GLP-1 medicines and retatrutide to recovery and longevity peptides.
News
UK Peptide Regulation Check: No Standalone MHRA Peptide Guidance Found
A 2026 UK peptide regulation check: no standalone March 2026 MHRA peptide research-chemical guidance was found; current rules still turn on medicines law, specials, enforcement, and claims.
20
Peptides tracked
10
Vendors reviewed
1
Clinics listed
3
Jurisdictions covered
Last updated 28 May 2026
Reviewed by PeptideUnicorn editorial board